One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). (Q44237365)
Jump to navigation
Jump to search
scientific article published in January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). |
scientific article published in January 2009 |
Statements
1 reference
One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). (English)
1 reference
Nabil Dib
1 reference
Jonathan Dinsmore
1 reference
Zaki Lababidi
1 reference
Bee White
1 reference
Susan Moravec
1 reference
Ann Campbell
1 reference
Amy Rosenbaum
1 reference
Katayoun Seyedmadani
1 reference
Wael A Jaber
1 reference
Craig S Rizenhour
1 reference
Edward Diethrich
1 reference
1 January 2009
1 reference
1 reference
Identifiers
1 reference